METICORTELONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Meticortelone, and what generic alternatives are available?
Meticortelone is a drug marketed by Schering and is included in one NDA.
The generic ingredient in METICORTELONE is prednisolone acetate. There are eighty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.
Summary for METICORTELONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 94 |
Clinical Trials: | 9 |
Patent Applications: | 4,919 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METICORTELONE at DailyMed |
Recent Clinical Trials for METICORTELONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Children's Oncology Group | Phase 2 |
Children's Oncology Group | Phase 1/Phase 2 |
National Cancer Institute (NCI) | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for METICORTELONE
US Patents and Regulatory Information for METICORTELONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | METICORTELONE | prednisolone acetate | INJECTABLE;INJECTION | 010255-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |